Valuation Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Cboe BZX
16:10:05 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 91.52 USD | +0.85% |
|
+0.97% | +7.52% |
Company Valuation: Edwards Lifesciences Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,883 | 46,128 | 46,246 | 43,663 | 49,471 | 52,303 | - | - |
| Change | - | -42.97% | 0.25% | -5.58% | 13.3% | 5.72% | - | - |
| Enterprise Value (EV) 1 | 80,616 | 45,956 | 45,198 | 40,285 | 45,843 | 48,672 | 47,108 | 45,292 |
| Change | - | -42.99% | -1.65% | -10.87% | 13.8% | 6.17% | -3.21% | -3.85% |
| P/E | 54.4x | 30.6x | 33.2x | 10.6x | 46.6x | 35.9x | 27.5x | 24.4x |
| PBR | 13.9x | 7.82x | 6.99x | 4.36x | 4.79x | 4.93x | 4.29x | 3.98x |
| PEG | - | 12.14x | -5.79x | 0x | -0.6x | 0.9x | 0.9x | 1.9x |
| Capitalization / Revenue | 15.5x | 8.57x | 7.7x | 8.03x | 8.15x | 7.74x | 7.04x | 6.4x |
| EV / Revenue | 15.4x | 8.54x | 7.53x | 7.41x | 7.56x | 7.2x | 6.34x | 5.54x |
| EV / EBITDA | 46.6x | 23.7x | 24.1x | 24.1x | 25.5x | 22.8x | 19.8x | 16.9x |
| EV / EBIT | 50.6x | 25.6x | 26.1x | 26.6x | 27.9x | 24.7x | 21.3x | 18.2x |
| EV / FCF | 57.3x | 47.2x | 47.9x | 139x | 34.3x | 57.3x | 29.3x | 24.9x |
| FCF Yield | 1.74% | 2.12% | 2.09% | 0.72% | 2.91% | 1.74% | 3.42% | 4.01% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.38 | 2.44 | 2.3 | 6.97 | 1.83 | 2.531 | 3.304 | 3.718 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 5,232 | 5,382 | 6,005 | 5,440 | 6,068 | 6,759 | 7,429 | 8,177 |
| EBITDA 1 | 1,729 | 1,936 | 1,879 | 1,670 | 1,800 | 2,137 | 2,384 | 2,687 |
| EBIT 1 | 1,594 | 1,796 | 1,734 | 1,514 | 1,644 | 1,971 | 2,212 | 2,484 |
| Net income 1 | 1,503 | 1,522 | 1,402 | 4,175 | 1,074 | 1,435 | 1,897 | 2,121 |
| Net Debt 1 | -267 | -172.7 | -1,048 | -3,378 | -3,628 | -3,631 | -5,195 | -7,011 |
| Reference price 2 | 129.55 | 74.61 | 76.25 | 74.03 | 85.25 | 90.74 | 90.74 | 90.74 |
| Nbr of stocks (in thousands) | 624,334 | 618,260 | 606,500 | 589,800 | 580,300 | 576,400 | - | - |
| Announcement Date | 26/01/22 | 31/01/23 | 06/02/24 | 11/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 35.86x | 7.2x | 22.78x | -.--% | 52.3B | ||
| 29.91x | 5.32x | 20.4x | 0.31% | 222B | ||
| 34.9x | 6.29x | 19.96x | 0.69% | 145B | ||
| 40.5x | 10.52x | 23.26x | -.--% | 130B | ||
| 17.95x | 3.67x | 11.91x | -.--% | 69.68B | ||
| 19.47x | 2.34x | 11.7x | 2.62% | 50.71B | ||
| 29.2x | 5.76x | 19.58x | 0.69% | 42.28B | ||
| 71.05x | 6.79x | 20.67x | -.--% | 39.87B | ||
| 20.08x | 5.57x | 14.39x | 1.15% | 33.37B | ||
| 41.85x | 6.82x | 24.05x | -.--% | 31.28B | ||
| Average | 34.08x | 6.03x | 18.87x | 0.55% | 81.74B | |
| Weighted average by Cap. | 33.23x | 6.28x | 19.53x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EW Stock
- Valuation Edwards Lifesciences Corporation
Select your edition
All financial news and data tailored to specific country editions
















